{
  "DOI": "10.1038/s41431-022-01055-4",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/s41431-022-01055-4",
  "alternative-id": [
    "1055"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "8 October 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Revised",
      "name": "revised",
      "order": 2,
      "value": "25 November 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 3,
      "value": "20 January 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 4,
      "value": "7 February 2022"
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "Authors are staff and member of the Committee of the Health Council of the Netherlands that has drawn up the report discussed in this paper."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Kalkman",
      "given": "Shona",
      "sequence": "first"
    },
    {
      "ORCID": "http://orcid.org/0000-0003-4052-7192",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Dondorp",
      "given": "Wybo",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2022,
        2,
        7
      ]
    ],
    "date-time": "2022-02-07T05:02:36Z",
    "timestamp": 1644210156000
  },
  "deposited": {
    "date-parts": [
      [
        2022,
        10,
        11
      ]
    ],
    "date-time": "2022-10-11T14:03:15Z",
    "timestamp": 1665496995000
  },
  "indexed": {
    "date-parts": [
      [
        2022,
        10,
        11
      ]
    ],
    "date-time": "2022-10-11T14:54:49Z",
    "timestamp": 1665500089114
  },
  "is-referenced-by-count": 2,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "10",
  "issued": {
    "date-parts": [
      [
        2022,
        2,
        7
      ]
    ]
  },
  "journal-issue": {
    "issue": "10",
    "published-print": {
      "date-parts": [
        [
          2022,
          10
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            2,
            7
          ]
        ],
        "date-time": "2022-02-07T00:00:00Z",
        "timestamp": 1644192000000
      }
    },
    {
      "URL": "https://www.springer.com/tdm",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            2,
            7
          ]
        ],
        "date-time": "2022-02-07T00:00:00Z",
        "timestamp": 1644192000000
      }
    }
  ],
  "link": [
    {
      "URL": "https://www.nature.com/articles/s41431-022-01055-4.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-022-01055-4",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-022-01055-4.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "1155-1158",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2022,
        2,
        7
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2022,
        2,
        7
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2022,
        10
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1038/ejhg.2016.126",
      "author": "ME Jansen",
      "doi-asserted-by": "publisher",
      "first-page": "10",
      "journal-title": "Eur J Hum Genet",
      "key": "1055_CR1",
      "unstructured": "Jansen ME, Metternick-Jones SC, Lister KJ. International differences in the evaluation of conditions for newborn bloodspot screening: a review of scientific literature and policy documents. Eur J Hum Genet. 2016;25:10–6.",
      "volume": "25",
      "year": "2016"
    },
    {
      "DOI": "10.1002/ajmg.a.31165",
      "author": "LF Ross",
      "doi-asserted-by": "publisher",
      "first-page": "914",
      "journal-title": "Am J Med Genet A.",
      "key": "1055_CR2",
      "unstructured": "Ross LF. Screening for conditions that do not meet the Wilson and Jungner criteria: the case of Duchenne muscular dystrophy. Am J Med Genet A. 2006;140:914–22.",
      "volume": "140",
      "year": "2006"
    },
    {
      "DOI": "10.1002/mrdd.20119",
      "author": "DB Bailey Jr.",
      "doi-asserted-by": "publisher",
      "first-page": "270",
      "journal-title": "Ment Retard Dev Disabil Res Rev",
      "key": "1055_CR3",
      "unstructured": "Bailey DB Jr., Beskow LM, Davis AM, Skinner D. Changing perspectives on the benefits of newborn screening. Ment Retard Dev Disabil Res Rev. 2006;12:270–9.",
      "volume": "12",
      "year": "2006"
    },
    {
      "key": "1055_CR4",
      "unstructured": "EURORDIS. The Voice of Rare Disease Patients in Europe. Key principles for newborn screening. Brussels: EURORDIS. https://eurordis.org/newbornscreening 2021."
    },
    {
      "DOI": "10.1542/peds.2005-2633O",
      "author": "D Alexander",
      "doi-asserted-by": "publisher",
      "first-page": "S350",
      "journal-title": "Pediatrics",
      "key": "1055_CR5",
      "unstructured": "Alexander D, van Dyck PC. A vision of the future of newborn screening. Pediatrics 2006;117:S350–4.",
      "volume": "117",
      "year": "2006"
    },
    {
      "DOI": "10.1542/peds.2016-2252",
      "doi-asserted-by": "crossref",
      "key": "1055_CR6",
      "unstructured": "Berg JS, Agrawal PB, Bailey DB Jr, Beggs AH, Brenner SE, Brower AM, et al. Newborn sequencing in genomic medicine and public health. Pediatrics. 2017;139:e20162252."
    },
    {
      "DOI": "10.3389/fgene.2021.662254",
      "author": "ZI Remec",
      "doi-asserted-by": "publisher",
      "first-page": "662254",
      "journal-title": "Front Genet.",
      "key": "1055_CR7",
      "unstructured": "Remec ZI, Trebusak Podkrajsek K, Repic Lampret B, Kovac J, Groselj U, Tesovnik T, et al. Next-generation sequencing in newborn screening: a review of current state. Front Genet. 2021;12:662254.",
      "volume": "12",
      "year": "2021"
    },
    {
      "key": "1055_CR8",
      "unstructured": "Health Council of the Netherlands. Screenen op niet-behandelbare aandoeningen vroeg in het leven [Screening for non-treatable disorders early in life]. The Hague: Health Council of the Netherlands https://www.gezondheidsraad.nl/documenten/adviezen/2020/09/30/screenen-op-niet-behandelbare-aandoeningen-vroeg-in-het-leven 2020."
    },
    {
      "DOI": "10.1002/14651858.CD003725.pub4",
      "doi-asserted-by": "crossref",
      "key": "1055_CR9",
      "unstructured": "Matthews E, Brassington R, Kuntzer T, Jichi F, Manzur AY. Corticosteroids for the treatment of Duchenne muscular dystrophy. Cochrane Database Syst Rev. 2016;5:CD003725."
    },
    {
      "DOI": "10.1016/S1474-4422(18)30115-7",
      "author": "CM McDonald",
      "doi-asserted-by": "publisher",
      "first-page": "389",
      "journal-title": "Lancet Neurol.",
      "key": "1055_CR10",
      "unstructured": "McDonald CM, Mercuri E. Evidence-based care in Duchenne muscular dystrophy. Lancet Neurol. 2018;17:389–91.",
      "volume": "17",
      "year": "2018"
    },
    {
      "DOI": "10.1007/s12519-019-00242-6",
      "author": "Q Ke",
      "doi-asserted-by": "publisher",
      "first-page": "219",
      "journal-title": "World J Pediatr.",
      "key": "1055_CR11",
      "unstructured": "Ke Q, Zhao ZY, Mendell JR, Baker M, Wiley V, Kwon JM, et al. Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophy. World J Pediatr. 2019;15:219–25.",
      "volume": "15",
      "year": "2019"
    },
    {
      "DOI": "10.1001/jamaneurol.2013.4808",
      "author": "F Tassone",
      "doi-asserted-by": "publisher",
      "first-page": "355",
      "journal-title": "JAMA Neurol.",
      "key": "1055_CR12",
      "unstructured": "Tassone F. Newborn screening for fragile X syndrome. JAMA Neurol. 2014;71:355–9.",
      "volume": "71",
      "year": "2014"
    },
    {
      "DOI": "10.1542/peds.2007-0820",
      "author": "DB Bailey Jr",
      "doi-asserted-by": "publisher",
      "first-page": "e693",
      "journal-title": "Pediatrics.",
      "key": "1055_CR13",
      "unstructured": "Bailey DB Jr, Skinner D, Davis AM, Whitmarsh I, Powell C. Ethical, legal, and social concerns about expanded newborn screening: fragile X syndrome as a prototype for emerging issues. Pediatrics. 2008;121:e693–704.",
      "volume": "121",
      "year": "2008"
    },
    {
      "DOI": "10.1136/fn.86.2.F91",
      "author": "EP Parsons",
      "doi-asserted-by": "publisher",
      "first-page": "F91",
      "journal-title": "Arch Dis Child Fetal Neonatal Ed.",
      "key": "1055_CR14",
      "unstructured": "Parsons EP, Clarke AJ, Hood K, Lycett E, Bradley DM. Newborn screening for Duchenne muscular dystrophy: a psychosocial study. Arch Dis Child Fetal Neonatal Ed. 2002;86:F91–5.",
      "volume": "86",
      "year": "2002"
    },
    {
      "DOI": "10.1542/peds.2009-0269",
      "author": "AM Plass",
      "doi-asserted-by": "publisher",
      "first-page": "e99",
      "journal-title": "Pediatrics.",
      "key": "1055_CR15",
      "unstructured": "Plass AM, van El CG, Pieters T, Cornel MC. Neonatal screening for treatable and untreatable disorders: prospective parents’ opinions. Pediatrics. 2010;125:e99–106.",
      "volume": "125",
      "year": "2010"
    },
    {
      "DOI": "10.1097/GIM.0b013e3181de695c",
      "author": "CH Wade",
      "doi-asserted-by": "publisher",
      "first-page": "317",
      "journal-title": "Genet Med.",
      "key": "1055_CR16",
      "unstructured": "Wade CH, Wilfond BS, McBride CM. Effects of genetic risk information on children’s psychosocial wellbeing: a systematic review of the literature. Genet Med. 2010;12:317–26.",
      "volume": "12",
      "year": "2010"
    },
    {
      "DOI": "10.1038/gim.2015.181",
      "author": "CE Wakefield",
      "doi-asserted-by": "publisher",
      "first-page": "755",
      "journal-title": "Genet Med.",
      "key": "1055_CR17",
      "unstructured": "Wakefield CE, Hanlon LV, Tucker KM, Patenaude AF, Signorelli C, McLoone JK, et al. The psychological impact of genetic information on children: a systematic review. Genet Med. 2016;18:755–62.",
      "volume": "18",
      "year": "2016"
    },
    {
      "DOI": "10.1542/peds.2019-1031",
      "doi-asserted-by": "crossref",
      "key": "1055_CR18",
      "unstructured": "Ross LF, Clayton EW. Ethical issues in newborn sequencing research: the case study of BabySeq. Pediatrics. 2019;144:e20191031."
    },
    {
      "author": "EP Parsons",
      "first-page": "17",
      "journal-title": "Community Genet.",
      "key": "1055_CR19",
      "unstructured": "Parsons EP, Clarke AJ, Hood K, Bradley DM. Feasibility of a change in service delivery: the case of optional newborn screening for duchenne muscular dystrophy. Community Genet. 2000;3:17–23.",
      "volume": "3",
      "year": "2000"
    },
    {
      "DOI": "10.1002/mus.24880",
      "author": "J Chung",
      "doi-asserted-by": "publisher",
      "first-page": "570",
      "journal-title": "Muscle Nerve.",
      "key": "1055_CR20",
      "unstructured": "Chung J, Smith AL, Hughes SC, Niizawa G, Abdel-Hamid HZ, Naylor EW, et al. Twenty-year follow-up of newborn screening for patients with muscular dystrophy. Muscle Nerve. 2016;53:570–8.",
      "volume": "53",
      "year": "2016"
    },
    {
      "DOI": "10.1038/ejhg.2012.301",
      "author": "SJ Moat",
      "doi-asserted-by": "publisher",
      "first-page": "1049",
      "journal-title": "Eur J Hum Genet.",
      "key": "1055_CR21",
      "unstructured": "Moat SJ, Bradley DM, Salmon R, Clarke A, Hartley L. Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK). Eur J Hum Genet. 2013;21:1049–53.",
      "volume": "21",
      "year": "2013"
    },
    {
      "DOI": "10.3390/ijns4010009",
      "author": "T Wotton",
      "doi-asserted-by": "publisher",
      "first-page": "9",
      "journal-title": "Int J Neonatal Screen.",
      "key": "1055_CR22",
      "unstructured": "Wotton T, Wiley V, Bennetts B, Christie L, Wilcken B, Jenkins G, et al. Are we ready for fragile X newborn screening testing? Lessons learnt from a feasibility study. Int J Neonatal Screen. 2018;4:9.",
      "volume": "4",
      "year": "2018"
    },
    {
      "DOI": "10.2353/jmoldx.2008.070073",
      "author": "F Tassone",
      "doi-asserted-by": "publisher",
      "first-page": "43",
      "journal-title": "J Mol Diagn",
      "key": "1055_CR23",
      "unstructured": "Tassone F, Pan R, Amiri K, Taylor AK, Hagerman PJ. A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations. J Mol Diagn. 2008;10:43–9.",
      "volume": "10",
      "year": "2008"
    },
    {
      "DOI": "10.1038/s41582-019-0203-3",
      "author": "IEC Verhaart",
      "doi-asserted-by": "publisher",
      "first-page": "373",
      "journal-title": "Nat Rev Neurol",
      "key": "1055_CR24",
      "unstructured": "Verhaart IEC, Aartsma-Rus A. Therapeutic developments for Duchenne muscular dystrophy. Nat Rev Neurol. 2019;15:373–86.",
      "volume": "15",
      "year": "2019"
    },
    {
      "DOI": "10.1001/jamaneurol.2015.3537",
      "author": "MA Gatheridge",
      "doi-asserted-by": "publisher",
      "first-page": "111",
      "journal-title": "JAMA Neurol.",
      "key": "1055_CR25",
      "unstructured": "Gatheridge MA, Kwon JM, Mendell JM, Scheuerbrandt G, Moat SJ, Eyskens F, et al. Identifying non-Duchenne muscular dystrophy-positive and false negative results in prior Duchenne muscular dystrophy newborn screening programs: a review. JAMA Neurol. 2016;73:111–6.",
      "volume": "73",
      "year": "2016"
    },
    {
      "DOI": "10.1038/s41431-019-0351-3",
      "author": "J Schuurmans",
      "doi-asserted-by": "publisher",
      "first-page": "691",
      "journal-title": "Eur J Hum Genet",
      "key": "1055_CR26",
      "unstructured": "Schuurmans J, Birnie E, van den Heuvel LM, Plantinga M, Lucassen A, van der Kolk DM, et al. Feasibility of couple-based expanded carrier screening offered by general practitioners. Eur J Hum Genet 2019;27:691–700.",
      "volume": "27",
      "year": "2019"
    },
    {
      "key": "1055_CR27",
      "unstructured": "VSOP Patient alliance for rare and genetic diseases. Letter to the State Secretary in response to the Health Council’s report ‘Screening for non-treatable disorders early in life’. Soest: VSOP. https://vsop.nl/actueel/de-vsop-pleit-voor-een-aangepast-besliskader-voor-de-hielprik/ 2020."
    },
    {
      "DOI": "10.1007/s00439-021-02269-0",
      "doi-asserted-by": "publisher",
      "key": "1055_CR28",
      "unstructured": "Newson AJ. The promise of public health ethics for precision medicine: the case of newborn preventive genomic sequencing. Hum Genet. 2021, https://doi.org/10.1007/s00439-021-02269-0. Online ahead of print."
    }
  ],
  "reference-count": 28,
  "references-count": 28,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/s41431-022-01055-4"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "The case for screening in early life for ‘non-treatable’ disorders: ethics, evidence and proportionality. A report from the Health Council of the Netherlands"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "30"
}